517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial

BACKGROUND: The aim of this pragmatic, embedded adaptive trial was to measure the effectiveness of subcutaneous sarilumab in addition to an evolving standard of care for clinical management of inpatients with moderate to severe COVID-19 disease (NCT04359901). The study is also a real-world demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Branch-Elliman, Westyn, Ferguson, Ryan, Doros, Gheorghe, Woods, Patricia, Leatherman, Sarah, Strymish, Judith, Datta, Rupak, Goswami, Rekha, Jankowich, Matthew, Shah, Nishant, Taylor, Thomas H, Page, Sarah T, Schiller, Sara, Shannon, Colleen, Hau, Cynthia, Flynn, Maura, Holmberg, Erika, Visnaw, Karen, Dhond, Rupali, Brophy, Mary, Monach, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690689/
http://dx.doi.org/10.1093/ofid/ofab466.716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690689/
http://dx.doi.org/10.1093/ofid/ofab466.716

Ejemplares similares